Chartwell Investment Partners LLC acquired a new position in Lantheus Holdings Inc (NASDAQ:LNTH) during the 4th quarter, HoldingsChannel reports. The fund acquired 78,123 shares of the medical equipment provider’s stock, valued at approximately $1,598,000.
Other large investors have also recently made changes to their positions in the company. Sei Investments Co. grew its stake in Lantheus by 189.6% in the third quarter. Sei Investments Co. now owns 7,829 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 5,126 shares in the last quarter. Bank of Montreal Can grew its stake in Lantheus by 371.6% in the fourth quarter. Bank of Montreal Can now owns 6,819 shares of the medical equipment provider’s stock worth $139,000 after purchasing an additional 5,373 shares in the last quarter. Teachers Retirement System of The State of Kentucky bought a new position in Lantheus in the second quarter worth approximately $141,000. LS Investment Advisors LLC grew its stake in Lantheus by 47.1% in the third quarter. LS Investment Advisors LLC now owns 9,306 shares of the medical equipment provider’s stock worth $166,000 after purchasing an additional 2,981 shares in the last quarter. Finally, Cambria Investment Management L.P. bought a new position in Lantheus in the third quarter worth approximately $198,000. 91.60% of the stock is currently owned by institutional investors.
In other news, insider Michael P. Duffy sold 21,655 shares of the stock in a transaction on Wednesday, January 10th. The stock was sold at an average price of $22.40, for a total transaction of $485,072.00. Following the completion of the sale, the insider now owns 156,784 shares in the company, valued at approximately $3,511,961.60. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO John W. Crowley sold 3,866 shares of the stock in a transaction on Tuesday, January 16th. The shares were sold at an average price of $23.52, for a total value of $90,928.32. The disclosure for this sale can be found here. 2.30% of the stock is owned by corporate insiders.
A number of research firms have weighed in on LNTH. Zacks Investment Research upgraded Lantheus from a “hold” rating to a “buy” rating and set a $27.00 target price for the company in a report on Saturday, January 27th. BidaskClub lowered Lantheus from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. ValuEngine lowered Lantheus from a “buy” rating to a “hold” rating in a report on Friday, December 1st. Finally, Credit Suisse Group upped their target price on Lantheus from $19.00 to $23.00 and gave the stock a “neutral” rating in a report on Friday, November 3rd. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. Lantheus currently has a consensus rating of “Buy” and an average target price of $24.75.
TRADEMARK VIOLATION NOTICE: This story was originally reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international copyright law. The correct version of this story can be accessed at https://www.chaffeybreeze.com/2018/02/21/chartwell-investment-partners-llc-acquires-new-position-in-lantheus-holdings-inc-lnth.html.
Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.
Want to see what other hedge funds are holding LNTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lantheus Holdings Inc (NASDAQ:LNTH).
Receive News & Ratings for Lantheus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus and related companies with MarketBeat.com's FREE daily email newsletter.